D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Newmark Group
NMRK
$2.73B
| $358K | ﹤0.01% |
42,879
-36,308
| -46% | -$344K |
|
3102
Resources Connection
RGP
$129M
| $358K | ﹤0.01% |
+21,652
| New | +$362K |
|
|
BITA
3103
DELISTED
Bitauto Holdings Limited
BITA
| $358K | ﹤0.01% |
22,473
+13,988
| +165% | +$257K |
|
3104
Tennant Co
TNC
$1.5B
| $357K | ﹤0.01% |
+5,743
| New | +$344K |
|
3105
CALL
Best Buy
BBY
$18B
| $355K | ﹤0.01% |
5,000
| – | – |
|
3106
PUT
Cognizant
CTSH
$21.5B
| $355K | ﹤0.01% |
4,900
-20,900
| -81% | -$1.46M |
|
3107
CALL
Iron Mountain
IRM
$38.2B
| $355K | ﹤0.01% |
+10,000
| New | +$353K |
|
3108
PUT
Medtronic
MDT
$107B
| $355K | ﹤0.01% |
+3,900
| New | +$349K |
|
3109
PUT
National Beverage
FIZZ
$2.87B
| $352K | ﹤0.01% |
12,200
+4,000
| +49% | +$142K |
|
3110
PUT
Rambus
RMBS
$10.4B
| $351K | ﹤0.01% |
33,600
| – | – |
|
|
BERY
3111
CALL
DELISTED
Berry Global Group, Inc.
BERY
| $350K | ﹤0.01% |
7,079
| – | – |
|
3112
BJ's Restaurants
BJRI
$1.41B
| $349K | ﹤0.01% |
7,392
-92,865
| -93% | -$4.66M |
|
3113
Ulta Beauty
ULTA
$20.4B
| $349K | ﹤0.01% |
1,000
-100
| -9% | -$30.2K |
|
3114
Kennametal
KMT
$2.68B
| $348K | ﹤0.01% |
+9,464
| New | +$346K |
|
3115
Enphase Energy
ENPH
$4.84B
| $346K | ﹤0.01% |
37,503
-122,561
| -77% | -$932K |
|
3116
SAP
SAP
$187B
| $346K | ﹤0.01% |
3,000
-216,788
| -99% | -$23.1M |
|
|
KDNY
3117
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $346K | ﹤0.01% |
17,407
+9,330
| +116% | +$163K |
|
3118
PUT
Ryanair
RYAAY
$29.5B
| $345K | ﹤0.01% |
+11,500
| New | +$333K |
|
|
AAWW
3119
CALL
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $344K | ﹤0.01% |
6,800
-2,300
| -25% | -$116K |
|
3120
Stagwell
STGW
$1.84B
| $343K | ﹤0.01% |
152,352
-110,125
| -42% | -$302K |
|
3121
Unitil
UTL
$1,000M
| $343K | ﹤0.01% |
6,338
-2,364
| -27% | -$123K |
|
|
OPI
3122
DELISTED
Office Properties Income Trust
OPI
| $342K | ﹤0.01% |
+12,382
| New | +$375K |
|
3123
Metropolitan Bank Holding Corp
MCB
$1.13B
| $341K | ﹤0.01% |
9,792
+594
| +6% | +$21.2K |
|
3124
Neurogene
NGNE
$696M
| $341K | ﹤0.01% |
6,318
-8,914
| -59% | -$450K |
|
3125
NMI Holdings
NMIH
$3.25B
| $340K | ﹤0.01% |
13,132
-22,734
| -63% | -$518K |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.